Bionano Genomics Inc (NAS:BNGO)
$ 0.904 -0.026 (-2.8%) Market Cap: 62.47 Mil Enterprise Value: 49.37 Mil PE Ratio: 0 PB Ratio: 0.63 GF Score: 44/100

Q3 2020 Bionano Genomics Inc Earnings Call Transcript

Nov 12, 2020 / 09:30PM GMT
Release Date Price: $5.73 (+2.36%)
Operator

Greetings, and welcome to Bionano Genomics, Inc. third quarter 2020 conference call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Ashley Robinson with Investor Relations. Thank you. You may proceed.

Ashley R. Robinson
LifeSci Advisors, LLC - MD

Thank you, Latania, and good afternoon, everyone. Welcome to the Bionano Genomics third quarter financial results conference call.

Leading the call today is Dr. Erik Holmlin, CEO; and he's joined by Chris Stewart, CFO of Bionano.

After market closed today, Bionano issued a press release announcing its financial results for the third quarter of 2020. A copy of the release can be found on the Investor Relations page of the company's website.

Before we begin, I would like to remind everyone that certain statements made during this conference call may be forward-looking, including statements about the company's strategic and commercialization plans, adoption of the Saphyr system, the advantages of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot